Cardlytics CDLX Institutional Ownership

Cardlytics, Inc. (NASDAQ:CDLX) has 43 institutional investors that have filed 13F reports for the period ending June 2026.

• Collectively, these holders controlled 30.2% of Cardlytics's outstanding shares in June 2026, down from 33.4% in March 2026.
• They increased total shares held in Cardlytics by 234.92% from last quarter, and the number of investors in CDLX decreased 51.14% annually.
• Activity in CDLX broke down as 42 buyers, 1 sellers, and 0 unchanged among 43 total holders.
• Combined, these investors held 1.74Mn shares in CDLX for June 2026, up by 1.22Mn shares quarter on quarter, and down 698.64K shares year over year.
• As of June 30, 2026, the biggest holder of Cardlytics is CAS Investment Partners, LLC at 470.99K shares, representing 8.18% of shares outstanding.
• The most significant purchases of CDLX for the quarter ending June 2026 came from VANGUARD CAPITAL MANAGEMENT LLC (218.61K), 683 Capital Management, LLC (200.0K), KPS Global Asset Management UK Ltd (121.88K), WORLDLY PARTNERS MANAGEMENT, LLC (115.8K), BlackRock, Inc. (84.65K).
• The largest sellers of Cardlytics for the quarter ending June 2026 were CAS Investment Partners, LLC (48.82K).
• Cardlytics's 10 largest shareholders as of June 2026 include CAS Investment Partners, LLC (470.99K), VANGUARD CAPITAL MANAGEMENT LLC (218.61K), 683 Capital Management, LLC (200.0K), KPS Global Asset Management UK Ltd (121.88K), WORLDLY PARTNERS MANAGEMENT, LLC (115.8K), BlackRock, Inc. (84.65K), RBF Capital, LLC (80.01K), GEODE CAPITAL MANAGEMENT, LLC (58.62K), Quinn Opportunity Partners LLC (46.24K), JANE STREET GROUP, LLC (39.54K) per Business Quant data.